Mount Sinai and BCRI partner to improve cardiovascular health and education in Latin America

BeiGene said its four-tar­get nat­ur­al killer cell ther­a­py col­lab­o­ra­tion with Shore­line Bio­sciences is over. And by reneg­ing on Shore­line’s iP­SC-NK cell tech­nol­o­gy, BeiGene los­es its

SAN DIEGO — Con­nor Dal­by’s shrieks filled his play­room, and the rest of the house. The teenag­er hushed when his mom, Kel­ley, asked a long-com­ing